Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: Correlation with clinical and biological features and outcome

British Journal of Haematology

Volumn 102, Issue 4, 1998, Pages 1025-1034

  Vinante, Fabrizio ^a   Rigo, Antonella ^a   Tecchio, Cristina ^a   Morosato, Lorella ^a   Nadali, Gianpaolo ^a   Ricetti, Maria Maddalena ^a   Krampera, Mauro ^a   Zanolin, Elisabetta ^a   Locatelli, Francesca ^a   Gallati, Harald ^b   Chilosi, Marco ^a   Pizzolo, Giovanni ^a,c  

^a UNIVERSITY OF VERONA   (Italy)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c OSPEDALE POLICLINICO   (Italy)

Author keywords

AML; Prognostic factors; Soluble TNFR; TNF; TNFR

Indexed keywords

TUMOR NECROSIS FACTOR RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; BLOOD LEVEL; CANCER GROWTH; CANCER SURVIVAL; CELL PROLIFERATION; DIAGNOSTIC VALUE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RETROSPECTIVE STUDIES; SOLUBILITY; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 7344228961     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00872.x     Document Type: Article

References (31)

1. Bazzoni, F. & Beutler, B. (1995) How do tumor necrosis factor receptors work? Journal of Inflammation, 45, 221-238.
2. Brockhaus, M., Schoenfeld, H.J., Schlaeger, E.J., Hunziker, W., Lesslauer, W. & Loetscher, H. (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America, 87, 3127-3131.
3. Carter, A., Haddad, N., Draxler, I., Israeli, E., Raz, B. & Rowe, J.M. (1996) Expression and role in growth regulation of tumour necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells. British Journal of Haematology, 92, 116-126.
4. Carter, A., Haddad, N., Draxler, I., Israeli, E., Raz, B. & Tatarsky, I. (1994) Respective effects of soluble interleukin-1 receptor and tumour necrosis factor receptor on IL-1 and TNF-alpha-induced DNA synthesis of common acute lymphoblastic leukaemia blasts in vitro. British Journal of Haematology, 86, 22-29.
5. Cox, D.R. (1972) Regression models and life-tables. Journal of the Royal Statistical Society, B, 34, 187-220.
6. Delwel, R., van Buitenen, C., Lowenberg, B. & Touw, I. (1992) Involvement of tumor necrosis factor (TNF) receptors p55 and p75 in TNF responses of acute myeloid leukemia blasts in vitro. Blood, 80, 1798-1803.
7. Dembic, Z., Loetscher, H., Gubler, V., Pan, Y.C., Lahm, H.W., Gentz, R., Brockhaus, M. & Lesslauer, W. (1990) Two human TNF receptors have similar extracellular but distinct intracellular domain sequences. Cytokine, 22, 231-237.
8. Elbaz, O., Budel, L.M., Hoogerbrugge, H., Touw, I.P., Delwel, R., Mahmoud, L.A. & Lowenberg, B. (1991a) Tumor necrosis factor regulates the expression of granulocyte-macrophage colony-stimulating factor and interleukin-3 receptors on human acute myeloid leukemia cells. Blood, 77, 989-995.
9. Elbaz, O., Budel, L.M., Hoogerbrugge, H., Touw, I.P., Delwel, R., Mahmoud, L.A. & Lowenberg, B. (1991b) Tumor necrosis factor (TNF) down regulates G-CSF receptor expression on human acute myeloid leukemia (AML) cells and granulocytes. Journal of Clinical Investigation, 8, 838-841.
10. Gruss, H.J. & Dower, S.K. (1995) The TNF ligand superfamily and its relevance for human diseases. Cytokines and Molecular Therapy, 1, 75-105.
11. Heaney, M.L. & Golde, D.W. (1996) Soluble cytokine receptors. Blood, 87, 847-857.
12. Heller, R.A., Song, K., Onasch, M.A., Fischer, W.H., Chand, D. & Ringold, D.M. (1990) Complementary DNA cloning of a receptor for human necrosis factor and demonstration of a shed form of the receptor. Proceedings of the National Academy of Sciences of the United States of America, 87, 6151-6155.
13. Higuchi, M. & Aggarwal, B.B. (1994) TNF induces internalization of the p60 receptor and shedding of the p80 receptor. Journal of Immunology, 152, 3550-3558.
14. Hoang, T., Levy, B., Onetto, N., Haman, A. & Rodriguez-Cimadevilla, J.C. (1989) Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor. Journal of Experimental Medicine, 170, 15-26.
15. Hsu, H., Xiong, J. & Goeddel, D.V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF-kappaB activation. Cell, 81, 495-504.
16. Hwang, C., Gatanaga, M., Granger, G. & Gatanaga, T. (1993) Mechanism of release of soluble forms of tumor necrosis factor/lymphotoxin receptors by phorbol myristate acetate-stimulated human THP-1 cells in vitro. Journal of Immunology, 151, 5631-5638.
17. Kaplan, E.L. & Meier, P. (1958) Non-parametric estimation from incomplete observations. Journal of the American Statistical Association, 53, 457-481.
18. + cells via p55 TNFα receptors. Blood, 84, 2506-2514.
19. Kobayashi, D., Watanabe, N., Yamauchi, N., Tsuji, N., Sato, T. & Niitsu, Y. (1997) Endogenous tumor necrosis factor as a predictor of doxorubicin sensitivity in leukemic patients. Blood, 89, 2472-2479.
20. Kohno, T., Brewer, M.T., Baker, S.L., Schwartz, P.E., King, M.W., Hale, K.K., Squires, C.H., Thompson, R.C. & Vannice, J.L. (1990) A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 87, 8331-8335.
21. Loetscher, H., Pan, Y.C., Lahm, H.W., Gentz, R., Brockhaus, M., Tabuchi, H. & Lesslauer, W. (1990) Molecular cloning and expression of the human 55 Kd tumor necrosis factor receptor. Cell, 61, 351-359.
22. McHugh, S.M. & Rowland, T.L. (1997) Thalidomide and derivatives: immunological investigations of tumor necrosis factor-alpha (TNF-α) inhibition suggest drugs capable of selective gene regulation. Clinical and Experimental Immunology, 110, 151-154.
23. Oster, W., Cicco, N.A., Klein, H., Hirano, T., Kishimoto, T., Lindemann, A., Mertelsmann, R. & Herrmann, F. (1989) Participation of the cytokines interleukin-6, tumor necrosis factor-alpha, and interleukin-1β secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control. Journal of Clinical Investigation, 84, 451-457.
24. Schall, T.J., Lewis, M., Koller, K.J., Lee, A., Rice, G.C., Wong, G.H.W., Galanaga, T., Granger, G.A., Lentz, R., Raab, H., Kohr, W.J. & Goeddel, D.V. (1990) Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell, 61, 361-370.
25. Smith, C.A., Davis, T., Anderson, D., Solam, L., Beckmann, M.P., Jerzy, R., Dower, S.K., Cosman, D. & Goodwin, R.G. (1990) A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science, 248, 1019-1023.
26. Todeschini, G., Meneghini, V., Pizzolo, G., Cassibba, V., Ambrosetti, A., Veneri, D., Nadali, G., Zanotti, R., Tecchio, C. & Perona, G. (1994) Daunorubicin dosage in induction phase is a major prognostic factor in long term results of adult acute lymphoblastic leukemia. Leukemia, 8, 376-381.
27. Todeschini, G., Tecchio, C., Meneghini, V., Pizzolo, G., Veneri, D., Zanotti, R., Ricetti, M., Solero, P., Aprili, F. & Perona, G. (1998) Estimated 6-year event-free survival of 55% in 60 consecutive adult acute lymphoblastic leukemia patients treated with an intensive phase II protocol based on high induction dose of daunorubicin. Leukemia, 12, 144-149.
28. Trentin, L., Pizzolo, G., Zambello, R., Agostini, C., Morosato, L., Sancetta, R., Adami, F., Vinante, F., Chilosi, M., Gallati, H. & Semenzato, G. (1995) Leukemic cells in hairy cell leukemia and B-cell chronic lymphocytic leukemia release soluble TNF receptors. Leukemia, 9, 1051-1055.
29. van den Heuvel-Eibrink, M.M., van der Holt, B., Boekhorst, P.A.W., Pieters, R., Schoester, M., Lowenberg, B. & Sonneveld, P. (1997) MDR1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia. British Journal of Haematology, 99, 76-83.
30. Vinante, F., Rigo, A., Tecchio, C., Patuzzo, C., Ricetti, M.M., Morosato, L., Cassatella, M.A., Chilosi, M. & Pizzolo, G. (1996) Preferential release of high amounts of interleukin-8 by myeloid blasts showing monocytic differentiation. Haematologica, 81, 195-200.
31. Vinante, F., Rigo, A., Vincenzi, C., Ricetti, M.M., Marrocchella, R., Chilosi, M., Cassatella, M.A., Bonazzi, L. & Pizzolo, G. (1993) IL-8 mRNA expression and IL-8 production by acute myeloid leukemia cells. Leukemia, 7, 1552-1556.